| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.BBADIS.2014.02.006 |
| P8608 | Fatcat ID | release_uct5m6olmvafffjbktc5b7uys4 |
| P3181 | OpenCitations bibliographic resource ID | 5047753 |
| P698 | PubMed publication ID | 24561654 |
| P2093 | author name string | Athanasios G. Papavassiliou | |
| Aristeidis G. Vaiopoulos | |||
| Kalliopi Ch. Athanasoula | |||
| P2860 | cites work | The fundamental role of epigenetic events in cancer | Q56421597 |
| Phase I trial of histone deacetylase inhibition by valproic acid followed by the topoisomerase II inhibitor epirubicin in advanced solid tumors: a clinical and translational study | Q80358623 | ||
| A randomized phase II study of two doses of vorinostat in combination with 5-FU/LV in patients with refractory colorectal cancer | Q82153622 | ||
| The role of microRNAs in colorectal cancer | Q84557483 | ||
| Positive Expression of LSD1 and Negative Expression of E-cadherin Correlate with Metastasis and Poor Prognosis of Colon Cancer | Q85893330 | ||
| Global cancer statistics | Q22241238 | ||
| Epigenetics Offer New Horizons for Colorectal Cancer Prevention | Q22252606 | ||
| Multiple Wnt/ß-Catenin Responsive Enhancers Align with the MYC Promoter through Long-Range Chromatin Loops | Q24300934 | ||
| ZEB1 represses E-cadherin and induces an EMT by recruiting the SWI/SNF chromatin-remodeling protein BRG1 | Q24307871 | ||
| A novel small molecule hydroxamate preferentially inhibits HDAC6 activity and tumour growth | Q24309277 | ||
| Molecular origins of cancer: Molecular basis of colorectal cancer | Q24617331 | ||
| An overview of epigenetics and chemoprevention | Q24623823 | ||
| Comprehensive molecular characterization of human colon and rectal cancer | Q24630415 | ||
| DNA methylation and microRNA dysregulation in cancer | Q26998741 | ||
| Epigenetics meets radiation biology as a new approach in cancer treatment | Q27014984 | ||
| Acetylation of non-histone proteins modulates cellular signalling at multiple levels | Q28294575 | ||
| Frameshift mutations of a chromatin-remodeling gene SMARCC2 in gastric and colorectal cancers with microsatellite instability | Q45777612 | ||
| Global DNA demethylation in gastrointestinal cancer is age dependent and precedes genomic damage | Q46846179 | ||
| Phase I and pharmacodynamic trial of the DNA methyltransferase inhibitor decitabine and carboplatin in solid tumors | Q46958949 | ||
| Long-range epigenetic silencing associates with deregulation of Ikaros targets in colorectal cancer cells | Q51547560 | ||
| EZH2 is regulated by ERK/AKT and targets integrin alpha2 gene to control Epithelial-Mesenchymal Transition and anoikis in colon cancer cells | Q53262663 | ||
| Global histone modification of histone H3 in colorectal cancer and its precursor lesions | Q53281697 | ||
| Statins augment the chemosensitivity of colorectal cancer cells inducing epigenetic reprogramming and reducing colorectal cancer cell 'stemness' via the bone morphogenetic protein pathway | Q54374200 | ||
| Polycomb group protein Bmi1 expression in colon cancers predicts the survival | Q54451921 | ||
| Class I and III HDACs and loss of active chromatin features contribute to epigenetic silencing of CDX1 and EPHB tumor suppressor genes in colorectal cancer. | Q54605417 | ||
| Prognostic impact of p300 expression in patients with colorectal cancer. | Q54723457 | ||
| Coupling of Glucose Deprivation with Impaired Histone H2B Monoubiquitination in Tumors | Q28729926 | ||
| Cancer epigenetics: from mechanism to therapy | Q29614799 | ||
| A phase I/II trial of vorinostat in combination with 5-fluorouracil in patients with metastatic colorectal cancer who previously failed 5-FU-based chemotherapy | Q33387793 | ||
| A phase I study of the safety and pharmacokinetics of the histone deacetylase inhibitor belinostat administered in combination with carboplatin and/or paclitaxel in patients with solid tumours | Q33390447 | ||
| Phase I study of bevacizumab, everolimus, and panobinostat (LBH-589) in advanced solid tumors | Q33402040 | ||
| A phase I dose-finding study of 5-azacytidine in combination with sodium phenylbutyrate in patients with refractory solid tumors | Q33752772 | ||
| Methylation pattern of the O6-methylguanine-DNA methyltransferase gene in colon during progressive colorectal tumorigenesis. | Q33775531 | ||
| EZH2 depletion blocks the proliferation of colon cancer cells | Q33963796 | ||
| Protocol for minimizing the risk of metachronous adenomas of the colorectum with green tea extract (MIRACLE): a randomised controlled trial of green tea extract versus placebo for nutriprevention of metachronous colon adenomas in the elderly populat | Q33996086 | ||
| Chromatin remodeling is required for gene reactivation after decitabine-mediated DNA hypomethylation. | Q34101643 | ||
| Genome-wide profiling of chromatin signatures reveals epigenetic regulation of MicroRNA genes in colorectal cancer. | Q34198100 | ||
| Cancer Genetics and Epigenetics: Two Sides of the Same Coin? | Q34287662 | ||
| Histone deacetylases and cancer. | Q34298745 | ||
| LINE-1 methylation shows little intra-patient heterogeneity in primary and synchronous metastatic colorectal cancer | Q34502664 | ||
| Phase II trial of romidepsin (NSC-630176) in previously treated colorectal cancer patients with advanced disease: a Southwest Oncology Group study (S0336) | Q34510205 | ||
| Curcumin modulates DNA methylation in colorectal cancer cells. | Q34608782 | ||
| Phase I clinical, pharmacokinetic and pharmacodynamic study of SB939, an oral histone deacetylase (HDAC) inhibitor, in patients with advanced solid tumours | Q34621838 | ||
| Role of nucleosomal occupancy in the epigenetic silencing of the MLH1 CpG island. | Q34712569 | ||
| HDAC Up-Regulation in Early Colon Field Carcinogenesis Is Involved in Cell Tumorigenicity through Regulation of Chromatin Structure | Q34749665 | ||
| Modulation of genetic and epigenetic biomarkers of colorectal cancer in humans by black raspberries: a phase I pilot study | Q34790860 | ||
| Impact of microRNAs on regulatory networks and pathways in human colorectal carcinogenesis and development of metastasis. | Q34976152 | ||
| SirT3 suppresses hypoxia inducible factor 1α and tumor growth by inhibiting mitochondrial ROS production | Q35100923 | ||
| Phase I study of the histone deacetylase inhibitor entinostat in combination with 13-cis retinoic acid in patients with solid tumours | Q35653852 | ||
| TCF12 protein functions as transcriptional repressor of E-cadherin, and its overexpression is correlated with metastasis of colorectal cancer | Q35710117 | ||
| Regulation of the potential marker for intestinal cells, Bmi1, by β-catenin and the zinc finger protein KLF4: implications for colon cancer | Q35763252 | ||
| Oligoamine analogues in combination with 2-difluoromethylornithine synergistically induce re-expression of aberrantly silenced tumour-suppressor genes | Q35778754 | ||
| Expression of HDAC1 and CBP/p300 in human colorectal carcinomas | Q36172244 | ||
| Notch1 counteracts WNT/β-catenin signaling through chromatin modification in colorectal cancer | Q36190689 | ||
| Phase I study of MGCD0103 given as a three-times-per-week oral dose in patients with advanced solid tumors | Q36408642 | ||
| β-Catenin and Peroxisome Proliferator-activated Receptor-δ Coordinate Dynamic Chromatin Loops for the Transcription of Vascular Endothelial Growth Factor A Gene in Colon Cancer Cells | Q36436120 | ||
| Loss of LSD1 (lysine-specific demethylase 1) suppresses growth and alters gene expression of human colon cancer cells in a p53- and DNMT1(DNA methyltransferase 1)-independent manner. | Q36474544 | ||
| Loss of imprinting and cancer | Q36687286 | ||
| Down-regulation of miR-21 Induces Differentiation of Chemoresistant Colon Cancer Cells and Enhances Susceptibility to Therapeutic Regimens | Q36723767 | ||
| Epigenetic regulation of colon cancer and intestinal stem cells | Q36736072 | ||
| MicroRNA-627 Mediates the Epigenetic Mechanisms of Vitamin D to Suppress Proliferation of Human Colorectal Cancer Cells and Growth of Xenograft Tumors in Mice | Q37043000 | ||
| Epigenetics and colorectal cancer pathogenesis | Q37061792 | ||
| DNA methylation and histone modifications of Wnt genes by genistein during colon cancer development. | Q37065358 | ||
| HDAC turnover, CtIP acetylation and dysregulated DNA damage signaling in colon cancer cells treated with sulforaphane and related dietary isothiocyanates | Q37378670 | ||
| Degrees make all the difference: the multifunctionality of histone H4 lysine 20 methylation | Q37424350 | ||
| Pharmacological inhibition of polycomb repressive complex-2 activity induces apoptosis in human colon cancer stem cells | Q37431211 | ||
| An evolutionary perspective of animal microRNAs and their targets | Q37598535 | ||
| DNA methylation: an introduction to the biology and the disease-associated changes of a promising biomarker. | Q37618053 | ||
| Interplay between microRNAs and the epigenetic machinery: an intricate network | Q37759740 | ||
| Colorectal Cancer Epigenetics: Complex Simplicity | Q37827277 | ||
| Genetic and epigenetic biomarkers of colorectal cancer | Q37884180 | ||
| Roles of the Polycomb group proteins in stem cells and cancer | Q37924588 | ||
| MicroRNA Dysregulation in Colon Cancer Microenvironment Interactions: The Importance of Small Things in Metastases. | Q37930489 | ||
| Epigenetics and chemoresistance in colorectal cancer: an opportunity for treatment tailoring and novel therapeutic strategies | Q37940106 | ||
| Epigenetic Regulation and Colorectal Cancer | Q37966769 | ||
| Epigenetic biomarkers of colorectal cancer: Focus on DNA methylation | Q37971844 | ||
| Epigenetics of colorectal cancer | Q37977477 | ||
| Targeting transcription factor corepressors in tumor cells | Q38004930 | ||
| The enigmatic role of H2Bub1 in cancer | Q38008101 | ||
| Epigenetic alterations involved in cancer stem cell reprogramming | Q38058972 | ||
| Mechanisms and functions of ATP-dependent chromatin-remodeling enzymes | Q38126255 | ||
| DNA methylation biomarkers as diagnostic and prognostic tools in colorectal cancer | Q38140769 | ||
| Clinical significance of the interaction between non-coding RNAs and the epigenetics machinery: challenges and opportunities in oncology | Q38152226 | ||
| Clinical significance of long intergenic noncoding RNA-p21 in colorectal cancer | Q39099143 | ||
| LSD1-mediated epigenetic modification contributes to proliferation and metastasis of colon cancer | Q39117867 | ||
| Genetic and Epigenetic Down-regulation of MicroRNA-212 Promotes Colorectal Tumor Metastasis via Dysregulation of MnSOD | Q39167027 | ||
| Cancer-associated upregulation of histone H3 lysine 9 trimethylation promotes cell motility in vitro and drives tumor formation in vivo. | Q39171307 | ||
| MicroRNA-137, an HMGA1 Target, Suppresses Colorectal Cancer Cell Invasion and Metastasis in Mice by Directly Targeting FMNL2 | Q39234754 | ||
| Inhibition of PCAF Histone Acetyltransferase, Cytotoxicity and Cell Permeability of 2-Acylamino-1-(3- or 4-Carboxy-phenyl)benzamides | Q39249234 | ||
| Comparative genome-wide DNA methylation analysis of colorectal tumor and matched normal tissues. | Q39256728 | ||
| 5-Aza-2'-deoxycytidine reactivates gene expression via degradation of pRb pocket proteins | Q39459572 | ||
| c-Jun N-terminal phosphorylation antagonises recruitment of the Mbd3/NuRD repressor complex | Q39613141 | ||
| Kaiso contributes to DNA methylation-dependent silencing of tumor suppressor genes in colon cancer cell lines | Q39939604 | ||
| Phase I study of MG98, an oligonucleotide antisense inhibitor of human DNA methyltransferase 1, given as a 7-day infusion in patients with advanced solid tumors. | Q39985716 | ||
| Long-range epigenetic silencing of chromosome 5q31 protocadherins is involved in early and late stages of colorectal tumorigenesis through modulation of oncogenic pathways. | Q40492521 | ||
| Kaiso-deficient mice show resistance to intestinal cancer | Q40725042 | ||
| BRAF mutation-specific promoter methylation of FOX genes in colorectal cancer | Q41056167 | ||
| DNA methylation of the p14ARF, RASSF1A and APC1A genes as an independent prognostic factor in colorectal cancer patients | Q42112284 | ||
| Mixed lineage leukaemia-4 regulates cell-cycle progression and cell viability and its depletion suppresses growth of xenografted tumour in vivo | Q42234071 | ||
| Global histone modification of H3K27 correlates with the outcomes in patients with metachronous liver metastasis of colorectal cancer | Q44054971 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | colorectal cancer | Q188874 |
| colorectal carcinoma | Q25493920 | ||
| P304 | page(s) | 971-80 | |
| P577 | publication date | 2014-07-01 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Biochimica et Biophysica Acta | Q864239 |
| P1476 | title | Epigenetic modifications in colorectal cancer: molecular insights and therapeutic challenges | |
| P478 | volume | 1842 |
| Q51374049 | Analysis of HDACi-Induced Changes in Chromosomal Passenger Complex Localization |
| Q64933972 | Blood-based DNA Methylation Biomarkers for Early Detection of Colorectal Cancer. |
| Q46234976 | C-X-C chemokine receptor type 5 gene polymorphism affects gene expression in CD4+ T cells and is associated with increased risk of colorectal cancer |
| Q35713627 | Combined evaluation of hexokinase 2 and phosphorylated pyruvate dehydrogenase-E1α in invasive front lesions of colorectal tumors predicts cancer metabolism and patient prognosis. |
| Q49627540 | DNA Methylation and Hydroxymethylation in Primary Colon Cancer and Synchronous Hepatic Metastasis. |
| Q89518530 | DNA sequence context as a marker of CpG methylation instability in normal and cancer tissues |
| Q64114290 | Downregulation of KLF13 through DNMT1-mediated hypermethylation promotes glioma cell proliferation and invasion |
| Q64975240 | Drugs Targeting Epigenetic Modifications and Plausible Therapeutic Strategies Against Colorectal Cancer. |
| Q35668617 | Epigenetic Regulation by Sulforaphane: Opportunities for Breast and Prostate Cancer Chemoprevention |
| Q28071714 | Epigenetics in diagnosis of colorectal cancer |
| Q40357382 | Epigenomic landscape of 5-hydroxymethylcytosine reveals its transcriptional regulation of lncRNAs in colorectal cancer. |
| Q88991278 | Flaxseed Bioactive Compounds and Colorectal Cancer Prevention |
| Q99638160 | Genome-wide DNA methylation analysis by MethylRad and the transcriptome profiles reveal the potential cancer-related lncRNAs in colon cancer |
| Q33820846 | High expression of polo-like kinase 1 is associated with early development of hepatocellular carcinoma |
| Q37295663 | IFN-α potentiates the direct and immune-mediated antitumor effects of epigenetic drugs on both metastatic and stem cells of colorectal cancer |
| Q90482823 | Interplay between NRF1, E2F4 and MYC transcription factors regulating common target genes contributes to cancer development and progression |
| Q55518170 | Long non-coding RNA FOXD2-AS1 contributes to colorectal cancer proliferation through its interaction with microRNA-185-5p. |
| Q36729488 | Long non-coding RNA ZFAS1 interacts with CDK1 and is involved in p53-dependent cell cycle control and apoptosis in colorectal cancer |
| Q49315313 | Mechanism of action of the atypical retinoid ST1926 in colorectal cancer: DNA damage and DNA polymerase α. |
| Q55665136 | MicroRNA-539 inhibits colorectal cancer progression by directly targeting SOX4. |
| Q36520345 | MicroRNA‑126 inhibits proliferation and metastasis by targeting pik3r2 in prostate cancer |
| Q38559669 | Molecular biomarkers in colorectal carcinoma. |
| Q92715583 | Mutation Spectrum of Cancer-Associated Genes in Patients With Early Onset of Colorectal Cancer |
| Q60936250 | NADH dehydrogenase complex I is overexpressed in incipient metastatic murine colon cancer cells |
| Q57816329 | Overexpression of long noncoding RNA NORAD in colorectal cancer associates with tumor progression |
| Q41839648 | Overexpression of the long non-coding RNA, linc-UBC1, is associated with poor prognosis and facilitates cell proliferation, migration, and invasion in colorectal cancer |
| Q51707175 | Pre-analytical variables of circulating cell-free nucleosomes containing 5-methylcytosine DNA or histone modification H3K9Me3. |
| Q52802632 | Prognostic DNA methylation markers for sporadic colorectal cancer: a systematic review |
| Q38840647 | Pyrimidinedione-mediated selective histone deacetylase 6 inhibitors with antitumor activity in colorectal cancer HCT116 cells |
| Q47797356 | Significance of histone methyltransferase SETDB1 expression in colon adenocarcinoma |
| Q39175486 | Targeting histone methylation for colorectal cancer |
| Q92730656 | The Intricate Interplay between Epigenetic Events, Alternative Splicing and Noncoding RNA Deregulation in Colorectal Cancer |
| Q55024083 | The Rho GTPase Rnd1 inhibits epithelial-mesenchymal transition in hepatocellular carcinoma and is a favorable anti-metastasis target. |
| Q38215665 | The role of epigenetics in colorectal cancer |
| Q41712337 | The role of pparγ and autophagy in ros production, lipid droplets biogenesis and its involvement with colorectal cancer cells modulation. |
| Q54982408 | Upregulated plasmacytoma variant translocation 1 promotes cell proliferation, invasion and metastasis in colorectal cancer. |
| Q37582692 | ZNF148 modulates TOP2A expression and cell proliferation via ceRNA regulatory mechanism in colorectal cancer. |
| Q37030215 | miR-422a is an independent prognostic factor and functions as a potential tumor suppressor in colorectal cancer |
| Q64899408 | miR‑200b‑3p inhibits proliferation and induces apoptosis in colorectal cancer by targeting Wnt1. |
Search more.